20th World Congress of Dermatology
?

Searching by Author's name

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Results of searching?: Bos?J.

IC1246
Tacrolimus ointment 0.03% (protopic) twice a day is more effective than once a day or conventional therapy in children with moderate to severe AD
P0191
Growth velocity assessments of paediatric patients in long-term vehicle-controlled studies with pimecrolimus (SDZ ASM 981) cream 1%
P0192
Tacrolimus ointment (protopic) 0.03% twice daily as the therapy of choice in young paediatric patients (2-6 years) with moderate to severe AD
P0205
Pimecrolimus (SDZ ASM 981) cream 1% can be safely used in conjunction with topical corticosteroids: results of a long term paediatric study
P0281
Pimecrolimus (SDZ ASM 981) cream reduces the number of flares and is steroid sparing: a 1-year, double-blind, controlled study in children
P1970
Alefacept improves psoriatic arthritis and reduces synovial inflammatory infiltrate


1st TO 5th JULY 2002
PARIS


Back to main menu

Foreword

Oral communications and co-opted speakers abstracts

Poster abstracts

Searching by Author's name

Searching by Article's number

?